Skip to content
sellNotable

Reuven Yeganeh sold $3.4M of HLSQ

director, owner at BiomX Inc.. 670,000 shares at an average of $5.00, traded Mar 12, 2026, filed Mar 13, 2026.

Warning score
60
Value
$3.4M
670,000 shares
Holdings after
0
-223% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $3.4M at market
    +25
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -53.3%, 3m -91.3%, 6m -79.5%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HLSQOct 9, 2026 · close 0.28
Since filing Mar 13, 2026: -95.4%SPY +18.4% · excess -113.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001213900-26-027698, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 11, 2026CConversion
Common Stock, $0.0001 par value per shareindirect: Pyu Pyu Capital LLC
+300,000$2.00$600k30,000Mar 13, 2026
Mar 12, 2026SOpen-market sale
Common Stock, $0.0001 par value per shareindirect: Pyu Pyu Capital LLC
-300,000$5.00$1.5M0Mar 13, 2026
Mar 13, 2026CConversion
Common Stock, $0.0001 par value per shareindirect: Pyu Pyu Capital LLC
+370,000$2.00$740k370,000Mar 13, 2026
Mar 13, 2026SOpen-market sale
Common Stock, $0.0001 par value per shareindirect: Pyu Pyu Capital LLC
-370,000$5.00$1.9M0Mar 13, 2026
Mar 12, 2026CConversion
Series Y Convertible Preferred Stockderivativeindirect: Pyu Pyu Capital LLC
-600$0.00$02,700Mar 13, 2026
Mar 13, 2026CConversion
Series Y Convertible Preferred Stockderivativeindirect: Pyu Pyu Capital LLC
-740$0.00$01,960Mar 13, 2026

Related signals

Other insiders at BiomX Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
60Notable
HLSQsell
BiomX Inc.
Reuven Yeganeh
director, owner
$4.9M
980,000 shares
-218%
12Weak
HLSQsell
BiomX Inc.
OrbiMed Israel BioFund GP Limited Partnership
owner
$9,280
24,344 shares
-0%
35Weak
HLSQsell
BiomX Inc.
Assaf Oron
Chief Business Officer
$4,072
10,914 shares
-100%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Reuven Yeganeh sold $3.4M of HLSQ | InsiderTell